Development of Imeglimin Electrospun Nanofibers as a Potential Buccal Antidiabetic Therapeutic Approach

The prevalence of type 2 diabetes (T2D) has been growing worldwide; hence, safe and effective antidiabetics are critically warranted. Recently, imeglimin, a novel tetrahydrotriazene compound, has been approved for use in T2D patients in Japan. It has shown promising glucose-lowering properties by im...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamer, Ali A., Alsaleh, Nasser B., Aodah, Alhassan H., Alshehri, Abdullah A., Almughem, Fahad A., Alqahtani, Sarah H., Alfassam, Haya A., Tawfik, Essam A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144366/
https://www.ncbi.nlm.nih.gov/pubmed/37111693
http://dx.doi.org/10.3390/pharmaceutics15041208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144366/
https://www.ncbi.nlm.nih.gov/pubmed/37111693
http://dx.doi.org/10.3390/pharmaceutics15041208

Ejemplares similares